MDMA Addiction and the FDA’s Rejection Of Psychedelic Drug Therapy
The topic of MDMA addiction and the FDA’s stance on psychedelic drug therapy is a complex and evolving issue. Recently, studies have explored MDMA’s therapeutic potential, particularly in treating conditions like PTSD. However, the FDA has been cautious, often rejecting or strictly regulating psychedelic therapies due to concerns about safety, efficacy, and the potential for abuse.